No CrossRef data available.
Article contents
Increased Cost-Effectiveness of Hepatitis B Vaccination Supported by Study
Published online by Cambridge University Press: 21 June 2016
Abstract
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
![Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'](https://static.cambridge.org/content/id/urn%3Acambridge.org%3Aid%3Aarticle%3AS0899823X00090929/resource/name/firstPage-S0899823X00090929a.jpg)
- Type
- Departments
- Information
- Copyright
- Copyright © The Society for Healthcare Epidemiology of America 1993
References
1.
Bloom, BS, Hillman, AL, Fendrick, AM, Schwartz, JS. A reappraisal of hepatitis B virus vaccination strategies using a cost-effectiveness analysis. Annals Intern Med. 1993;118:298–306.CrossRefGoogle Scholar
2.
Centers for Disease Control. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 1991;40(no. RR-13):1–25.Google Scholar